The CONTIPRO holding has been involved in the research, development and biotechnological production of active ingredients for the cosmetic and pharmaceutical industries for over twenty years. With excellent production quality and extensive research facilities, it is one of the world’s leading manufacturers of hyaluronic acid and derived applications.
The holding places a huge emphasis on innovation and in-house research, which explains why almost half of its employees are R&D lab experts.
The oldest of the holding’s companies, Contipro Pharma, specializes in the manufacture of sodium hyaluronate pharmaceutical grade and other active substances for the pharmaceutical industry and finished pharmaceutical products made from hyaluronic acid.
Contipro Biotech, which produces hyaluronic acid cosmetic grade and other active ingredients for products to counter the effects of skin ageing, was founded in 1997.
In 2013 Contipro Biotech introduced the laboratory device for the nanofiber production - 4SPIN.